SCHEMBL3343040

SCHEMBL3343040

Cc1cn(-c2ccc(C)c(N)c2)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR2E1 Q9Y466 2/20 0.48
CYP3A4 P08684 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP19A1 P11511 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
CYP2E1 P05181 1/20 0.46
CYP2A6 P11509 1/20 0.46
KDM4E B2RXH2 2/20 0.45
MEN1 O00255 2/20 0.45
MAPT P10636 2/20 0.45
KMT2A Q03164 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MAOA P21397 4/20 0.45
MAOB P27338 4/20 0.45
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15442444 0.88 NR2E1 (0.49) NR2E1CYP3A4CYP1A2CYP2D6CYP19A1
SCHEMBL9701793 0.86 NR2E1 (0.48) NR2E1CYP3A4CYP1A2CYP2D6CYP19A1
SCHEMBL1824198 0.81 NR2E1 (0.43) NR2E1CYP3A4CYP1A2CYP2D6CYP19A1
SCHEMBL3405576 0.80 NR2E1 (0.56) NR2E1CYP3A4CYP1A2CYP2D6CYP19A1
SCHEMBL3344599 0.80 KMT2A (0.51) CYP3A4CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL22394099 0.79 CYP1A2 (0.46) NR2E1CYP3A4CYP1A2CYP2D6CYP19A1
SCHEMBL27985278 0.79 CYP1A2 (0.65) NR2E1CYP3A4CYP1A2CYP2D6CYP19A1
SCHEMBL264998 0.78 CYP1A2 (0.56) NR2E1CYP3A4CYP1A2CYP2D6CYP19A1
SCHEMBL15222204 0.78 MAOA (0.50) NR2E1CYP3A4CYP1A2CYP2D6CYP19A1
SCHEMBL1824196 0.78 CYP3A4 (0.46) NR2E1CYP3A4CYP1A2CYP2D6CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 NR2E1 382/4885CYP3A4 1590/4885CYP1A2 1833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.